Scarica l'app Stockscreener
71.52
1.67%
-1.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GEHC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$72.86
Aprire:
$72.37
Volume 24 ore:
1.33M
Relative Volume:
0.28
Capitalizzazione di mercato:
$32.82B
Reddito:
$19.80B
Utile/perdita netta:
$2.18B
Rapporto P/E:
15.06
EPS:
4.75
Flusso di cassa netto:
$1.37B
1 W Prestazione:
-3.08%
1M Prestazione:
-2.03%
6M Prestazione:
-9.60%
1 anno Prestazione:
-7.61%
Intervallo 1D:
$71.50
$72.71
Intervallo di 1 settimana:
$71.55
$74.16
Portata 52W:
$57.65
$94.80
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Nome
Ge Healthcare Technologies Inc
Settore
Industria
Telefono
833-735-1139
Indirizzo
500 WEST MONROE STREET, CHICAGO
Confronta GEHC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
71.53 | 32.82B | 19.80B | 2.18B | 1.37B | 4.75 |
|
ABT
Abbott Laboratories
|
132.84 | 232.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
101.79 | 148.00B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
373.37 | 146.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.36 | 112.11B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.39 | 44.79B | 5.54B | 4.18B | 623.10M | 7.00 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Aggiornamento | UBS | Sell → Neutral |
| 2025-03-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-26 | Downgrade | UBS | Neutral → Sell |
| 2024-09-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-09-09 | Iniziato | JP Morgan | Neutral |
| 2024-08-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | HSBC Securities | Buy |
| 2024-02-12 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-30 | Iniziato | Jefferies | Hold |
| 2023-11-27 | Downgrade | UBS | Neutral → Sell |
| 2023-09-19 | Iniziato | Citigroup | Buy |
| 2023-08-25 | Iniziato | Argus | Buy |
| 2023-08-16 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | BofA Securities | Neutral |
| 2023-06-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Iniziato | Oppenheimer | Outperform |
| 2023-04-26 | Iniziato | UBS | Neutral |
| 2023-04-19 | Iniziato | Piper Sandler | Overweight |
| 2023-04-10 | Iniziato | BTIG Research | Neutral |
| 2023-03-13 | Iniziato | Evercore ISI | Outperform |
| 2023-02-17 | Iniziato | Mizuho | Buy |
| 2023-01-19 | Iniziato | Redburn | Buy |
Mostra tutto
Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie
GE HealthCare launches next-gen intraoperative ultrasound - MassDevice
GE HealthCare Releases bkActiv S Series Intraoperative Ultrasounds - Medical Product Outsourcing
Weight Monitoring and Body Temperature Monitoring Devices - openPR.com
GEHC Stock Declines Despite Expansion in Precision Care Capabilities - TradingView
Is GE HealthCare Technologies Stock Underperforming the Nasdaq? - MSN
BTIG reiterates buy rating on GE HealthCare stock, citing stable growth - Investing.com India
GE HealthCare integrates proprietary features with MIM Encore software By Investing.com - Investing.com India
GE Healthcare Launches Enhanced Version of MIM Encore Imaging Software - Diagnostic and Interventional Cardiology
GE HealthCare integrates its imaging tech with MIM Software tools - Modern Healthcare
GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software - MassDevice
GE HealthCare Technologies (NasdaqGS:GEHC) Enhances Diagnostic Confidence With MIM Encore Integration - Yahoo Finance
GE HealthCare and MIM Software release integrated imaging platform - Yahoo
GE HealthCare Reveals MIM Encore Digital Imaging and Workflow Tools - Medical Product Outsourcing
GE HealthCare integrates proprietary features with MIM Encore software - Investing.com Australia
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions - Business Wire
Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization - TipRanks
Is GE HealthCare Technologies Stock Underperforming The Nasdaq? - Barchart.com
$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & - GlobeNewswire
GE HealthCare issues $1.5 billion in senior notes By Investing.com - Investing.com Nigeria
GE HealthCare issues $1.5 billion in senior notes - Investing.com Australia
GE Healthcare Issues $1.5 Billion in Senior Notes - TipRanks
Capital Research Global Reports 4.8% Passive Stake In GE Healthcare As Of May 30 - marketscreener.com
A closer look at GE HealthCare's new affordable cardiac CT scanner - Cardiovascular Business
Tata Memorial Centre ties up with Wipro GE to set up cancer research centre - Business Standard
Tata Memorial Centre and Wipro GE HealthCare Partner to Launch Cancer Research & Innovation Centre in India - eHealth Magazine
Wipro GE HealthCare inks MoU with Tata Memorial Centre to establish Cancer Research & Innovation Centre - BioSpectrum India
GE HealthCare inks MoU with Tata Memorial Centre to establish Cancer Research & Innovation Centre - BioSpectrum India
Tata Memorial Centre signs MoU with GE HealthCare for advanced cancer research - Healthcare Radius
GE HealthCare: The Demand Is Just Too Strong To Ignore (NASDAQ:GEHC) - Seeking Alpha
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks - The Motley Fool
GE Healthcare Announces $1.5 Billion Notes Offering - TipRanks
Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.
Tata Memorial Centre signs MoU with GE Healthcare to set up cancer research centre at TMC Mumbai - BusinessLine
Tata Memorial Centre, Wipro GE HealthCare sign MoU to Establish Cancer Research & Innovation Centre - ET HealthWorld
Tata Memorial, GE HealthCare Partner for Cancer Research - Rediff MoneyWiz
Tata Memorial Centre signs MoU with GE HealthCare to establish ‘Cancer Research & Innovation Centre’ - Pharmabiz.com
GE HealthCare Files For Offering Of $650 Million 4.800% Senior Notes Due 2031 - marketscreener.com
GE HealthCare Technologies : Kalbe and GE HealthCare Launch Indonesia’s First CT-Scanner Production Facility - marketscreener.com
North America 3D 4D Technology Market Size, Share Projections - openPR.com
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer - Quantisnow
DBS Bank Adjusts Price Target on GE Healthcare Technologies to $90 From $80, Maintains Buy Rating - marketscreener.com
GE HealthCare Technologies (GEHC): Company Profile, Stock Price, News, Rankings - Fortune
Wall Street Zen Upgrades GE HealthCare Technologies (NASDAQ:GEHC) to “Buy” - Defense World
GE Healthcare Says Updated NCCN Guidelines Recommend Use of FES PET Imaging for Breast Cancer - marketscreener.com
GE HealthCare secures stockholder approval for executive pay - Investing.com India
Major Breakthrough: NCCN Guidelines Recommend New Imaging Technology for Hard-to-Detect Breast Cancer - Stock Titan
GE HealthCare secures stockholder approval for executive pay By Investing.com - Investing.com South Africa
GE Healthcare Holds Annual Stockholders Meeting - TipRanks
Anesthesia Device Market Is Booming So Rapidly 2025-2032 -| GE Healthcare, Septodont Inc., Draegerwerk AG & Co - openPR.com
359,988 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Nvidia Unveils Foundation Models For Humanoids, Eyes 'Era of Robotics' As AI Spend Accelerates - Benzinga
Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ge Healthcare Technologies Inc Azioni (GEHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rott Roland | CEO, Imaging |
Nov 05 '24 |
Option Exercise |
40.40 |
13,275 |
536,310 |
37,573 |
| Rott Roland | CEO, Imaging |
Nov 06 '24 |
Sale |
86.48 |
3,577 |
309,339 |
24,298 |
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):